Modeling North Atlantic nor'easters with modern wave forecast models

Author Posting. © Her Majesty the Queen in Right of Canada, 2018. This article is posted here by permission of American Geophysical Union for personal use, not for redistribution. The definitive version was published in Journal of Geophysical Research: Oceans 123 (2018): 533–557, doi:10.1002/2017JC012868.Three state-of-the-art operational wave forecast model systems are implemented on fine-resolution grids for the Northwest Atlantic. These models are: (1) a composite model system consisting of SWAN implemented within WAVEWATCHIII® (the latter is hereafter, WW3) on a nested system of traditional structured grids, (2) an unstructured grid finite-volume wave model denoted “SWAVE,” using SWAN physics, and (3) an unstructured grid finite element wind wave model denoted as “WWM” (for “wind wave model”) which uses WW3 physics. Models are implemented on grid systems that include relatively large domains to capture the wave energy generated by the storms, as well as including fine-resolution nearshore regions of the southern Gulf of Maine with resolution on the scale of 25 m to simulate areas where inundation and coastal damage have occurred, due to the storms. Storm cases include three intense midlatitude cases: a spring Nor'easter storm in May 2005, the Patriot's Day storm in 2007, and the Boxing Day storm in 2010. Although these wave model systems have comparable overall properties in terms of their performance and skill, it is found that there are differences. Models that use more advanced physics, as presented in recent versions of WW3, tuned to regional characteristics, as in the Gulf of Maine and the Northwest Atlantic, can give enhanced results.NOAA-funded IOOS/SURA; BIO Grant Number: NA11NOS0120141; Canadian Panel on Energy R & D Grant Number: 1B00.003C; Fisheries and Oceans Canada's Aquatic Climate Change Adaptation Program Grant Number: MAR-92018-07-2

The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats

Background and purpose: We focused on the, yet undescribed, therapy effect of the stable gastric pentadecapeptide BPC 157 in hippocampal ischemia/reperfusion injuries, after bilateral clamping of the common carotid arteries in rats. The background is the proven therapy effect of BPC 157 in ischemia/reperfusion injuries in different tissues. Furthermore, there is the subsequent oxidative stress counteraction, particularly when given during reperfusion. The recovering effect it has on occluded vessels, results with activation of the alternative pathways, bypassing the occlusion in deep vein thrombosis. Finally, the BPC 157 therapy benefits with its proposed role as a novel mediator of Roberts' cytoprotection and bidirectional effects in the gut-brain axis. ----- Materials and methods: Male Wistar rats underwent bilateral clamping of the common carotid arteries for a 20-min period. At 30 s thereafter, we applied medication (BPC 157 10 µg/kg; or saline) as a 1 ml bath directly to the operated area, that is, trigonum caroticum. We documented, in reperfusion, the resolution of the neuronal damages sustained in the brain, resolution of the damages reflected in memory, locomotion, and coordination disturbances, with the presentation of the particular genes expression in hippocampal tissues. ----- Results: In the operated rats, at 24 and 72 hr of the reperfusion, the therapy counteracted both early and delayed neural hippocampal damage, achieving full functional recovery (Morris water maze test, inclined beam-walking test, lateral push test). mRNA expression studies at 1 and 24 hr, provided strongly elevated (Egr1, Akt1, Kras, Src, Foxo, Srf, Vegfr2, Nos3, and Nos1) and decreased (Nos2, Nfkb) gene expression (Mapk1 not activated), as a way how BPC 157 may act. ----- Conclusion: Together, these findings suggest that these beneficial BPC 157 effects may provide a novel therapeutic solution for stroke

Hepatoprotective effect of BPC 157, a 15-amino acid peptide, on liver lesions induced by either restraint stress or bile duct and hepatic artery ligation or CCl4 administration. A comparative study with dopamine agonists and somatostatin.

The hepatoprotective effects of a newly synthesized 15 amino acid fragment code named BPC 157 was evaluated in comparison with the reference standards (bromocriptine, amantadine and somatostatin) in various experimental models of liver injury in rats: 24 h-bile duct+hepatic artery ligation 48 h-restraint stress and CCl4 administration. BPC 157 administered either intragastrically or intraperitoneally, significantly prevented the development of liver necrosis or fatty changes in rats subjected to 24 h bile duct + hepatic artery ligation, 48 h-restraint stress, CCl4 treatment (1 ml/kg i.p., sacrifice 48 h thereafter). The other reference drugs had either little or no protective actions in these models. Noteworthy, the laboratory test results for bilirubin, SGOT, SGPT fully correlated with the macro/microscopical findings. Thus, on the basis of consistent protective effect of BPC 157, possible clinical application in liver diseases is now warranted